Skip to main navigation Skip to search Skip to main content

A kinase inhibitor screen identifies a dual cdc7/CDK9 inhibitor to sensitise triple-negative breast cancer to EGFR-targeted therapy

Research output: Contribution to journalArticleAcademicpeer-review

53 Citations (Scopus)
50 Downloads (Pure)
Original languageUndefined/Unknown
Article number77
JournalBreast Cancer Research
Volume21
DOIs
Publication statusPublished - 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Research programs

  • EMC MM-03-86-01

Cite this